Skip to content

Labor and Delivery Doula Program to Reduce Perinatal Morbidity and Mortality in Kansas

Labor and Delivery Doula Program to Reduce Perinatal Morbidity and Mortality in Kansas

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07157059
Acronym
Doula
Enrollment
30
Registered
2025-09-05
Start date
2023-05-12
Completion date
2024-11-01
Last updated
2026-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Black Maternal and Infant Health, Doula Care, Pregnancy Related, Prenatal Care

Brief summary

The study was done to learn how doula-enhanced care provided to Black birthing people improved perceived communication and quality care.

Interventions

BEHAVIORALDoula Care

Participants assigned to the Doula care group received care from the doula pre, during, and post delivery.

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER
BioNexus KC
CollaboratorUNKNOWN
Blue KC (Blue Cross Blue Shield)
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Black birthing people * Received care and plan to delivery at the University of Kansas Medical Center * Scored positive to social determinants of health screener * Gestational age between 14-27.6 weeks at enrollment

Exclusion criteria

* Pregnancy not viable or pregnancy not intrauterine on ultrasound * Patients who are not willing to be randomized into not receiving doula enhanced * Patients who do not plan to delivery at the University of Kansas Health System * Non-Black birthing people. * Planned cesarean section * Patients with a known major fetal anomaly * Non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
Perceptions of Provider CommunicationStudy enrollment through 6-weeks postpartumAssess patient's perception of their quality of communication with their provider using a Likert scale survey (ie. did the patient feel comfortable asking their prenatal provider questions regarding their health, did the patient feel listened to by their provider. Survey scale was 1 to 5 and correlated with agreement or disagreement. Reporting Likert's mean score as surveys were collected at three study timepoints (1. Baseline at study enrollment, 2. Immediate postdelivery, 3. 6-weeks postpartum); higher mean scores indicated more responses in disagreement.
Perceptions of Maternal CareStudy enrollment through 6-weeks postpartumAssess patient's perceptions of maternal care using a Likert scale survey (i.e. their physician spending time with the patient talking to them about their labor and delivery expectations) Survey scale was 1 to 5 and correlated with agreement or disagreement. Reporting Likert's mean score as surveys were collected at three study timepoints (1. Baseline at study enrollment, 2. Immediately post-delivery, 3. 6-weeks postpartum); higher mean scores indicated more responses in disagreement.

Secondary

MeasureTime frameDescription
Perinatal Outcome - Gestational Age (GA) at Delivery14-28 weeks GA through deliveryAssess gestational age (GA) at delivery by collecting data from their patient surveys and chart. GA at delivery (write number with one decimal place - "weeks.days". For example, 23 weeks and 4 days = 23.4)
Perinatal Outcome - Number of Participants With Preterm <37 Weeks Births14-28 weeks GA through deliveryAssess preterm \<37 weeks births by collecting data from their patient surveys and chart.
Perinatal Outcome - Number of Participants With Cesarean Sections14-28 weeks GA through deliveryAssess cesarean sections by collecting data from their patient surveys and chart.
Perinatal Outcome - Number of Participants With Gestational Hypertension/Preeclampsia14-28 weeks GA through deliveryAssess gestational hypertension/preeclampsia diagnosis by collecting data from their patient surveys and chart.
Neonatal MorbidityBirth/deliveryAssess neonatal morbidity by collecting neonatal 5-min Appearance, Pulse, Grimace, Activity, Respiration (APAGAR) score \<7. Each of the five criteria can be scored 0-2 with a possible total test score ranging from 0-10 with three subcategories; reassuring: score 7-10, moderately abnormal: 4-6 and low: 0-3. A higher score indicates better neonatal outcomes.
Antepartum DepressionStudy enrollment through deliveryAssess antepartum depression using Edinburgh depression screening tool. Edinburgh score scale range is from 0 to 30, a lower score is better as it indicates a participant is less likely to experience depression; the test denotes the following scoring interpretations for total scores: 0-6: minimal depression, 7-13: mild depression, 14-19: moderate depression, 19-30: severe depression. Reporting mean score for the antepartum phase of the study; participants were 14-28 weeks gestation at their study enrollment visit and mean gestational age at delivery for the doula-enhanced group was 37 weeks 5days and 38 weeks 1day for the routine care group.
Postpartum DepressionBirth (delivery) through 6-weeks postpartumAssess postpartum depression using Edinburgh depression screening tool. Edinburgh score scale range is from 0 to 30, a lower score is better as it indicates a participant is less likely to experience depression; the test denotes the following scoring interpretations for total scores: 0-6: minimal depression, 7-13: mild depression, 14-19: moderate depression, 19-30: severe depression. Reporting mean score for the postpartum phase in study participation starting post-delivery during their hospital admission until 6-weeks postpartum.
Maternal Pain ManagementDelivery through hospital dischargeAssess pain management by using the Numerical Rating Scale (NRS) was used for patient's perception of postpartum pain. Zero (0) is the minimum score, which represents the patient reporting no pain, 10 is the maximum score which represents the patient reporting the most intense pain possible. Lower scores are associated with lower postpartum pain perception (better outcome) and higher scores are associated with higher postpartum pain perception (worse outcome) from delivery (mean gestational age at delivery for the doula-enhanced group was 37 weeks 5days and 38 weeks 1day for the routine care group) until hospital discharge.
Lactation Status - Number of Participants Lactating and BreastfeedingBirthAssess lactation status by asking and recording participants response about initiating lactation and breastfeeding during their labor and delivery admission.
Lactation Status - Number of Participants Lactating and Breastfeeding After L&D DischargeBirth through 6-weeks postpartumAssess lactation status from birth after labor and delivery discharge to 6-week postpartum, by asking and recording participants' responses about their lactation and breastfeed state during their postpartum visits.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAngela Martin, MD

University of Kansas Medical Center

Baseline characteristics

Characteristic
Advanced Maternal Age (AMA)1 Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
14 Participants
Age, Continuous29 years
History of Cesarean Section3 Participants
Nulliparous4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
26 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
United States
26 participants
Sex: Female, Male
Female
12 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 14
other
Total, other adverse events
0 / 120 / 14
serious
Total, serious adverse events
0 / 120 / 14

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026